Blog Posts

Follow along as we discuss the latest changes across the pharmaceutical, biotechnology, medical technology and life science sectors.

  • 2024 A Year in Review

    2024 A Year in Review

    As we approach the close of 2024, it’s essential to reflect on our achievements, growth, and the incredible progress we’ve made together. This year has been transformative, marked by milestones that position the Adjutor Healthcare Group for even greater success in 2025. As we look forward, we remain committed to innovation, collaboration, and delivering exceptional…

  • Advertising and Promotional Material Review for Therapeutic Goods in Australia

    Advertising and Promotional Material Review for Therapeutic Goods in Australia

    Navigating advertising compliance for therapeutic goods in Australia can feel like walking a tightrope. With multiple advertising laws enforced by different regulators, businesses must tread carefully to avoid penalties or legal complications.

  • Understanding TGA GMP Clearance

    Understanding TGA GMP Clearance

    Understanding TGA Good Manufacturing Practice (GMP) requirements for Australian Regulatory Submissions Good Manufacturing Practice (GMP) is vital in ensuring the quality, safety, and efficacy of the therapeutic goods for human use (including sunscreens). In Australia, the Therapeutic Goods Administration (TGA) oversees the implementation and enforcement of GMP standards to uphold the integrity of the pharmaceutical…

  • Choosing the Right Regulatory Affairs Consultant

    Choosing the Right Regulatory Affairs Consultant

    Whether you are part of an established team, a start-up, an SME, or a founder, navigating the stringent requirements of the Medical Technology, Biotechnology, and Pharmaceutical (MTP) sectors can be complex and challenging. This is where partnering with the right Regulatory Affairs Consultant becomes invaluable. Understanding the Role of a Regulatory Affairs Consultant A regulatory…

  • Cell and Gene Therapies Regulation

    Cell and Gene Therapies Regulation

    Navigating the Regulation of Cell and Gene Therapies in Australia and New Zealand Globally, cell and gene therapies are revolutionising modern medicine, offering groundbreaking treatments for life-threatening conditions including cancer, genetic disorders and rare diseases. However, despite the pace of scientific innovation, regulatory frameworks in many countries, including Australia and New Zealand, have struggled to…

  • Medical Device Registration in Australia

    Medical Device Registration in Australia

    Key considerations in navigating the regulatory process to register a medical device in Australia. Registering a medical device in Australia is a complex but crucial process that ensures the safety and performance of devices entering the healthcare market. Navigating the regulatory requirements of the Therapeutic Goods Administration (TGA) can be daunting, particularly for new manufacturers…

  • How to Register a Medicine in Australia

    How to Register a Medicine in Australia

    Six ways to register a medicine in Australia: Understanding the complexities of medicine registration. In the dynamic landscape of pharmaceuticals, securing registration for a new medicine requires a nuanced understanding of regulatory procedures and individual client needs. The process involves meticulous planning and strategic vision to ensure successful registration. However, beyond the intricacies of registration,…

  • Enter the Dragon: Navigating Hong Kong’s Medicines Regulatory System in 2024

    Enter the Dragon: Navigating Hong Kong’s Medicines Regulatory System in 2024

    The Year of the Dragon stands as a fitting emblem for Hong Kong’s medicines regulatory system, symbolising strength, resilience, and vigilant oversight

  • Custom-made Medical Devices in Australia: Now it’s Personal(ised)

    Custom-made Medical Devices in Australia: Now it’s Personal(ised)

    Recent changes in TGA Medical Device Regulations In December 2020, TGA released a new Personalised Medical Device Guideline along with a suite of new names and definitions that have shaken up the niche and specialised Custom-made Medical Devices sector. The new guidance reflects amendments to the Therapeutic Goods (Medical Devices) Regulations 2002, meaning that compliance